Displaying items by tag: school of medicine

This genetic risk score may help health care providers identify the risk of heart disease earlier and take preventive measures.
UAB-led national study shows using blood pressure medication to treat pregnant women with chronic hypertension improves pregnancy outcomes, including a decrease in severe preeclampsia and preterm birth.
UAB Medicine will provide sideline physicians, preseason and postseason player physicals, mental health services, nutritionist consultations, clinical services, an employee health database and other services.
COVID-related acute kidney injury peaked in 10- to 15-year-olds and 70- to 75-year-olds, suggesting age is not the sole determinant in severity of illness from COVID-19.
Vendors at the event will offer health screenings, interactive activities, and information focused on health, wellness, physical activity, education and good nutrition.
UAB graduate and professional programs are well represented in the annual U.S. News & World Report rankings.
Researchers have been awarded a $2.6 million, four-year National Institutes of Health grant to evaluate a safer and more durable stent design, using techniques licensed through the UAB Harbert Institute for Innovation and Entrepreneurship by the UAB spinoff company Endomimetics LLC.
A UAB study shows that bone marrow transplant recipients have a shorter lifespan as compared to their counterparts.
UAB nutrition experts provide five practical ways you can start living a healthier life.
The $3 million Mark Foundation for Cancer Research grant was awarded to UAB to study the interplay of inflammation and clonal expansion in leukemia.
With 100 percent of the class of 2022 matching into residency positions, UAB students will continue their medical education at 82 institutions in 30 states across the country.
UAB primary care providers discuss screenings, immunizations, diet, exercise and other women’s health-related illnesses.
The monoclonal antibody cocktail is deliverable via a nasal dose, and it is also effective against SARS, MERS and several coronavirus cold viruses. The antibodies are engineered for long-acting effectiveness, potentially lasting a year or more when used in humans.
UAB’s Warner Huh was recognized by the American Cancer Society for his continued leadership within the community.
Page 30 of 168